pharmacodynamics

Pharmacodynamics

The study of the biochemical and physiological effects of drugs on the body and the mechanisms by which these effects are produced.

Therapeutic Objective

The goal of achieving the desired therapeutic effect of a drug while minimizing adverse effects.

Dose-Response Relationship

The correlation between the dose of a drug and the intensity of the response it produces.

Dose-Response Curve Phases

Three phases that help understand the minimum effective dose, maximum achievable effect, and necessary dosage adjustments.

Tailoring Treatment

Adjusting the dosage to achieve the desired intensity of response in clinical practice.

Maximal Efficacy

The largest effect that a drug can produce, represented by the height of the dose-response curve.

Clinical Relevance of Maximal Efficacy

Higher maximal efficacy is not always better; it should match the patient's needs.

Relative Potency

The amount of drug required to produce an effect, which is not necessarily related to maximal efficacy.

Drug-Receptor Interactions

The process by which drugs interact with receptors to produce effects.

Receptors

Functional macromolecules in cells that interact with drugs, including enzymes and regulatory molecules.

Binding Mechanism

The generally reversible interaction of a drug with its receptor, which can mimic or block endogenous molecules.

Types of Receptors

Four primary families include cell membrane-embedded enzymes, ligand-gated ion channels, G-protein coupled receptor systems, and transcription factors.

Agonists

Drugs that activate receptors, mimicking the action of endogenous substances, with both affinity and high intrinsic activity.

Antagonists

Drugs that prevent receptor activation by endogenous molecules, having affinity but no intrinsic activity.

Noncompetitive Antagonists

Bind irreversibly to receptors, reducing the maximal response that agonists can elicit.

Competitive Antagonists

Bind reversibly to receptors, competing with agonists for binding.

Partial Agonists

Drugs with moderate intrinsic activity that produce a weaker response than full agonists and can act as both agonists and antagonists.

Receptor Sensitivity

The dynamic nature of receptors that can change due to continuous drug exposure, leading to downregulation or upregulation.

Clinical Implication of Receptor Sensitivity

Adjusting drug dosages is necessary when receptors become desensitized or hypersensitive.

Receptorless Drugs

Drugs like antacids and osmotic diuretics that produce effects through physical or chemical interactions rather than binding to receptors.

Interpatient Variability

Differences in patient responses to the same drug dose due to genetic, physiological, and environmental factors.

Therapeutic Index

A measure of a drug’s safety, calculated as the ratio between the lethal dose (LD50) and the effective dose (ED50).

High Therapeutic Index

Indicates a safer drug that requires less careful monitoring.

Low Therapeutic Index

Indicates a drug that requires careful dosage and monitoring due to safety concerns.